How can you tell if nattokinase is working?

You have been taking nattokinase for six weeks, and you feel exactly the same.

That is the expected result, not a failure. When researchers measured what a single 2,000 FU dose actually does to the body, every change they detected stayed inside the normal laboratory range [1] — including D-dimer, Factor VIII and clotting time.

Nattokinase works below the threshold of sensation. This guide covers the one marker you can track at home, the labs a physician can order, and the signals people wrongly read as progress.

Table of Contents

1. Why You Cannot Feel Nattokinase Working
2. What Actually Changes, and on What Timeline
3. Blood Pressure: The One Marker You Can Track Yourself
4. The Lab Markers a Physician Can Order
5. What Is Not a Sign It Is Working
6. When Nattokinase May Genuinely Be Doing Nothing
7. Knowing What Is Actually Inside the Capsule
8. Frequently Asked Questions
9. Conclusion
10. Research References

1. Why You Cannot Feel Nattokinase Working

Most supplements people judge by feel come with built-in sensory feedback. Caffeine changes alertness within 30 minutes. Melatonin produces drowsiness. Nattokinase produces neither, because the process it participates in — the breakdown of fibrin in circulating blood — has no nerve endings attached to it.

The most precise measurement of what a dose actually does comes from a double-blind crossover study in 12 healthy men who took either 2,000 FU or placebo, with blood drawn at 2, 4, 6 and 8 hours. D-dimer rose at 6 and 8 hours, Factor VIII activity fell at 4 and 6 hours, and clotting time lengthened at 2 and 4 hours [1] — a clear, reproducible fingerprint of activity.

The critical detail is what the authors reported next: every one of those changes stayed inside the normal reference range, and no participant reported any side effect. The enzyme was doing something measurable to blood chemistry while the people in the study noticed nothing at all. That is the correct mental model. If you are waiting for a sensation to confirm your 100 mg capsule is working, you are waiting for a signal the biology does not produce. The underlying fibrinolytic mechanism explains why.

2. What Actually Changes, and on What Timeline

Nattokinase research operates on three separate clocks, and confusing them is the most common reason people conclude the supplement has failed after ten days.

• Hours: Fibrinolytic markers shift within 2 to 8 hours of a single 2,000 FU dose, then return toward baseline.
• Weeks: Blood pressure changes emerged over 8 weeks in both major randomised trials.
• Months: Arterial imaging endpoints required 12 months of daily use at far higher doses.

On the eight-week clock, the evidence is reasonably consistent. The 2008 randomised trial enrolled 86 adults with untreated systolic pressure between 130 and 159 mmHg; 73 completed it, and the nattokinase group ended 5.55 mmHg lower in systolic and 2.84 mmHg lower in diastolic pressure [3] than controls. A North American trial using K2-removed nattokinase at 100 mg daily for 8 weeks saw average diastolic pressure fall from 87 to 84 mmHg, and from 86 to 81 mmHg in men [5]. Pooling six randomised trials and 546 participants, a 2023 meta-analysis put the average effect at 3.45 mmHg systolic and 2.32 mmHg diastolic [4].

Those are real but small numbers, and their size is the whole problem for self-assessment. A 3 to 5 mmHg shift is invisible without disciplined measurement. The month-scale endpoints are further out of reach: a 12-month study of 1,062 participants averaging 67.5 years of age found meaningful reductions in arterial plaque and intima-media thickness at 10,800 FU per day, while 3,600 FU per day produced nothing [6]. That study was retrospective and uncontrolled, so it carries less weight than the randomised evidence above. Either way, that endpoint requires a carotid ultrasound, not a mirror. Our guide to what the blood pressure trials actually found breaks the data down further.

3. Blood Pressure: The One Marker You Can Track Yourself

Of everything nattokinase has been studied for, exactly one endpoint is measurable at home with a validated upper-arm cuff. If you want an answer to whether it is doing anything for you, this is it — but only if you measure the way the trials did.

The joint policy statement from the American Heart Association and American Medical Association is specific. Take two readings at least one minute apart, morning and evening, for a preferred 7 days — 28 readings, with a minimum of 12 across 3 days [8]. Average every reading. Scanning the numbers by eye to form an impression is explicitly discouraged, because that is how people talk themselves into results that are not there.

Technique matters more than most people expect. The AHA notes that a reading taken over clothing can be off by 5 to 50 points [11]. Set against a genuine effect of roughly 3 to 5 mmHg, careless measurement does not merely add noise — it drowns the signal entirely.

• Use a validated upper-arm cuff on a bare arm, correctly sized
• Empty your bladder; avoid caffeine, alcohol, smoking and exercise for 30 minutes beforehand
• Sit with back supported, feet flat and uncrossed, arm at heart level, and rest 5 minutes before the first reading [10]
• Do not talk during measurement

The practical protocol is simple: run a full 7-day baseline before your first capsule, then repeat the identical 7-day block at week 8. Compare the two averages. That single comparison will tell you more than eight weeks of intuition.

4. The Lab Markers a Physician Can Order

Beyond blood pressure, everything nattokinase has been shown to influence requires a blood draw and a clinician's order. It is worth understanding what these tests can and cannot tell you before asking for them.

D-dimer is the marker most often suggested online, and it is the one most likely to mislead. It has high sensitivity but low specificity, a plasma half-life of only 6 to 8 hours, and rises with pregnancy, trauma, malignancy, recent surgery and liver disease [9]. A single reading tells you almost nothing about a supplement, and because the fibrinolytic response peaks within hours of a dose, timing alone can flip the result.

Fibrinogen, Factor VII and Factor VIII have moved in nattokinase trials, and the North American study also recorded a fall in von Willebrand factor among female participants [5], though at a weaker significance threshold than the blood pressure findings. A lipid panel is the most routinely available option, and the 12-month, 1,062-participant study reported reductions in triglycerides, total cholesterol and LDL — but at 10,800 FU daily, not the standard 2,000 FU dose.

An honest caveat: most physicians will not order coagulation panels to monitor a supplement, and there is no clinical guideline supporting it. If you already have annual bloodwork, comparing lipids and fibrinogen year over year costs nothing extra. Requesting a D-dimer specifically to audit your capsules is unlikely to be granted, and would be difficult to interpret if it were.

5. What Is Not a Sign It Is Working

This section matters more than any other on this page, because the most perceptible effects associated with nattokinase are the ones you must never interpret as success.

Bruising more easily, cuts bleeding longer than usual, nosebleeds, bleeding gums, heavier periods, or blood in urine or stool are adverse signals, not efficacy signals. They indicate the effect has gone further than intended, and the correct response is to stop and contact a healthcare provider — not to conclude the supplement is finally doing its job. A published case report describes acute cerebellar haemorrhage in a 52-year-old woman with prior ischaemic stroke who added nattokinase at 400 mg daily for 7 days while taking aspirin [7], with multiple cerebral microbleeds visible on MRI. A separate report documents mechanical valve thrombosis after a patient substituted nattokinase for warfarin [12].

Anyone taking warfarin, apixaban, rivaroxaban, aspirin or clopidogrel should not begin nattokinase without physician oversight, and nobody should treat it as a replacement for prescribed anticoagulation. Our article on nattokinase as a natural blood thinner covers these interactions in depth, and the full side effect profile is worth reading before you start.

Two further non-signals: feeling warmer, more energetic or "lighter" has never been measured as a nattokinase outcome in any of the 6 trials included in the 2023 meta-analysis, and a single low blood pressure reading is statistical noise — which is precisely why the AHA protocol requires 28 of them.

6. When Nattokinase May Genuinely Be Doing Nothing

The largest and longest randomised trial of nattokinase deserves more attention than it usually receives. Researchers randomised 265 adults with a median age of 65.3 and no clinical cardiovascular disease to 2,000 FU daily or placebo, then followed them with carotid ultrasound every 6 months. After a median of three years, they found no difference in arterial thickness, arterial stiffness, blood pressure or any laboratory measure [2].

The explanation is not that nattokinase is inert — it is that baseline determines what is available to change. The 2008 trial enrolled people with systolic pressure of 130 to 159 mmHg, and the North American trial screened for systolic ≥130 or diastolic ≥90 mmHg. Both found effects. The three-year trial enrolled healthy, low-risk adults with nothing elevated to begin with, and found none. You cannot lower a number that is already normal, and if your blood pressure sits at 112/70, an 8-week experiment will show you nothing regardless of what the enzyme is doing.

Dose is the second variable. At 2,000 FU, the evidence supports blood pressure endpoints; the imaging endpoints required 10,800 FU daily for 12 months, and 3,600 FU daily achieved nothing across the same 1,062-participant study. Delivery is the third: nattokinase is a protein, and a capsule that releases in the stomach exposes the enzyme to acid before absorption, which is why the standard protocol is one capsule on an empty stomach. Our dosage and timing guide sets out the specifics.

7. Knowing What Is Actually Inside the Capsule

When an effect is invisible by nature, the only real assurance available is verification of what you are actually swallowing. Fibrinolytic units are an activity measure, not a weight — a label can state 2,000 FU while the enzyme inside has degraded, and no sensation will alert you to the difference.

BioAbsorb Nattokinase Enzyme delivers 100 mg providing 2,000 FU per capsule — the same dose used in both the 2008 blood pressure trial and the three-year prevention study, taken as one capsule daily on an empty stomach. Every batch is third-party tested to confirm at least 2,000 FU of activity, alongside screening for heavy metals, gluten and microbial contaminants.

Three formulation choices matter for anyone trying to interpret their own results. The capsule uses DRcaps delayed-release technology, protecting the enzyme from stomach acid without the phthalates and plasticizers found in conventionally enteric-coated capsules. The formula is free of vitamin K2 — relevant because the North American trial that recorded diastolic reductions used K2-removed nattokinase, and because K2 complicates matters for anyone on warfarin or already supplementing it. And it is non-GMO, 100% vegetarian and free of gluten, nuts, eggs, dairy, fish and shellfish, manufactured in a Canadian GMP-certified facility. At $49.87 for 180 capsules, a six-month supply works out to roughly $0.28 per day.

Frequently Asked Questions

How long should I take nattokinase before deciding it is not working?

Eight weeks is the evidence-based window, because that is the duration used in both randomised blood pressure trials. Run a 7-day home blood pressure baseline before your first capsule and an identical 7-day block at week 8, then compare the averages. Anything shorter than 8 weeks cannot answer the question.

Will a D-dimer test show whether nattokinase is working?

Not reliably. D-dimer has low specificity and a half-life of just 6 to 8 hours [9], so the result depends heavily on when you last took a dose and on unrelated factors including recent surgery, infection and pregnancy. It is a diagnostic tool for suspected clots, not a supplement monitor.

I bruise more easily since starting nattokinase. Is that a sign it is working?

No — treat it as a reason to stop and speak with a healthcare provider. Easier bruising and prolonged bleeding indicate an effect on haemostasis that has exceeded what is intended, and the risk is meaningfully higher for anyone also taking aspirin or an anticoagulant. It is a safety signal, never a confirmation of benefit.

Can I tell it is working from how I feel — more energy, warmer hands?

Those outcomes have not been measured in any of the 6 randomised trials pooled in the 2023 meta-analysis [4], which assessed blood pressure and lipid markers rather than subjective wellbeing. Changes in perceived energy over an 8-week period have many plausible causes, and attributing them to a fibrinolytic enzyme is not supported by the evidence.

Does taking it with food stop it from working?

The standard protocol across the research is a single daily dose on an empty stomach, since nattokinase is a protein and food slows and complicates its passage. If you have been taking it with meals and seen no change at week 8, correcting the timing before drawing conclusions is reasonable.

Should I stop if my blood pressure has not moved after 8 weeks?

That depends entirely on your starting point. If your baseline was already normal, there was nothing available to reduce — and the three-year trial in 265 healthy low-risk adults found no measurable change of any kind [2]. Discuss it with your physician rather than escalating the dose on your own.

Conclusion

The honest answer is that nattokinase gives you almost nothing to feel, and the one effect you can verify at home — a roughly 3.45 mmHg average systolic reduction [4] — only becomes visible through disciplined measurement over 8 weeks. Track it properly, treat any bleeding change as a stop signal rather than a success, and involve your physician if you take anticoagulants. If you want a capsule whose activity is verified rather than assumed, BioAbsorb Nattokinase Enzyme is third-party tested for 2,000 FU per capsule.

Research References

1. A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles. Scientific Reports, Vol. 5 (2015). Double-blind crossover trial in 12 healthy men; a single 2,000 FU dose raised D-dimer at 6 and 8 hours, reduced Factor VIII activity at 4 and 6 hours, and prolonged activated partial thromboplastin time at 2 and 4 hours, with all changes remaining within normal reference range.
2. Nattokinase atherothrombotic prevention study: A randomized controlled trial. Clinical Hemorheology and Microcirculation, Vol. 78, Issue 4 (2021). 265 adults of median age 65.3 without clinical cardiovascular disease took 2,000 FU or placebo for a median of three years, with no significant difference in carotid intima-media thickness, arterial stiffness, blood pressure or any laboratory measure.
3. Effects of nattokinase on blood pressure: a randomized, controlled trial. Hypertension Research, Vol. 31, Issue 8 (2008). 86 adults with untreated systolic pressure of 130–159 mmHg received 2,000 FU or placebo for 8 weeks; net reductions were 5.55 mmHg systolic and 2.84 mmHg diastolic among the 73 completers.
4. Nattokinase supplementation and cardiovascular risk factors: a systematic review and meta-analysis of randomized controlled trials. Reviews in Cardiovascular Medicine, Vol. 24, Issue 8 (2023). Pooled 6 randomised trials and 546 participants, finding average reductions of 3.45 mmHg systolic and 2.32 mmHg diastolic versus placebo.
5. Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial. Integrated Blood Pressure Control, Vol. 9 (2016). 79 hypertensive adults took 100 mg of K2-removed nattokinase or placebo for 8 weeks; diastolic pressure fell from 87 to 84 mmHg overall and from 86 to 81 mmHg in men. The study was sponsored by the distributor of the nattokinase product tested.
6. Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: a clinical study with 1,062 participants. Frontiers in Cardiovascular Medicine, Vol. 9 (2022). Retrospective, non-randomised study without a placebo control group. Participants averaging 67.5 years showed reduced carotid plaque, intima-media thickness and lipids after 12 months at 10,800 FU per day, while 3,600 FU per day was ineffective. A corrigendum was issued in 2022 correcting baseline characteristics.
7. Cerebellar hemorrhage provoked by combined use of nattokinase and aspirin in a patient with cerebral microbleeds. Internal Medicine, Vol. 47, Issue 5 (2008). Case report of acute cerebellar haemorrhage in a 52-year-old woman with prior ischaemic stroke after 7 days of nattokinase 400 mg daily alongside aspirin. Causality cannot be established given her clinical history.
8. Self-measured blood pressure monitoring at home: a joint policy statement from the American Heart Association and American Medical Association. Circulation, Vol. 142, Issue 4 (2020). Specifies two readings at least one minute apart, morning and evening, for a preferred 7 days, averaging all readings rather than assessing them visually.
9. D-Dimer Test. StatPearls, National Center for Biotechnology Information (2025). Describes D-dimer's high sensitivity, low specificity, 6-to-8-hour plasma half-life, and the conditions that produce false elevations.
10. Monitoring Your Blood Pressure at Home. American Heart Association (2024). Sets out correct cuff technique, including at least five minutes of quiet rest before the first reading and placement on bare skin rather than over clothing.
11. Monitoring blood pressure at home can be tricky. Here's how to do it right. American Heart Association News (2022). Notes that a reading taken over clothing can be inaccurate by 5 to 50 points.
12. Nattokinase. Drugs.com professional monograph (2026). Summarises adverse event reports including mechanical valve thrombosis following substitution of nattokinase for warfarin, and notes no adverse reactions in trials of up to 7 months.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.